Kimberly L. Dodge-Kafka, PhDProfessor, Department of Cell BiologyCalhoun Cardiology Center Director, MD/PhD combined degree program
|
Degree | Institution | Major |
---|---|---|
BS | Texas A&M University | Zoology |
PhD | University of Texas Health Science Center | Signal Transduction |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Howard Hughes Medical Institute, Vollum Institute, Oregon Health and Science University | Postdoctoral work in the laboratory of Dr. John D. Scott, Ph. D., FRS. Research focused on defining the function of the mAKAP complex in the heart. |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Osborn Award for Excellence in Graduate School Teaching | UCHC |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
Faculty Recruitment Committee for Calhoun Cardiology Center | Advisory Committee | Member | UConn Health | University | 2022 | 2022 |
NIH CSR Special Emphasis Panel, Fellowship: Cell Biology, Developmental Biology, and Bioengineering | Study Section | member | External | National | 2020 | |
Co-Director of MD/PhD committee | Education Committee | University | 2017 | |||
Molecular and Integrative Signal Transduction Study Section | Study Section | Ad Hoc | External | National | 2017 | 2017 |
PhD admissions Committee | Education Committee | Chair | UConn Health | International | 2015 | 2016 |
First Year Advisor for graduate students | Advisory Committee | member | UConn Health | University | 2015 | 2019 |
MD/PhD Sterling Committee | Education Committee | member | UConn Health | University | 2015 | |
Biomedical Sciences Curriculum Committee | Education Committee | member | UConn Health | Local | 2014 | |
Academic Advancement Committee | Education Committee | member | UConn Health | Local | 2014 | |
Chair-Committee for Biomedical Science representation at the Connecticut Science Festival | Other | Chair | UConn Health | Local | 2013 | 2014 |
Advisory Board for the Center for Cell Analysis and Modeling | Advisory Committee | UConn Health | Local | 2013 | ||
Graduate Faculty Committee | Education Committee | UConn-Storrs | State | 2013 | ||
Medical Research Council, England | Professional/Scientific Organization | Ad Hoc Grant Reviewer | External | International | 2010 | 2010 |
Search Committee for Associate Dean of the Graduate School | Advisory Committee | Member | UConn Health | University | 2010 | 2010 |
MMSB Strategic Planning committee | Advisory Committee | Member | UConn Health | University | 2009 | |
Member-American Society for Biochemistry and Molecular Biology. | Study Section | Member | External | National | 2007 | |
Co-chair for the organization of a student/post-doctoral retreat at the yearly meetings. This retreat will be held before the annual meeting to allow for additional training and socialization of the students and post-doctorate fellows. | Professional/Scientific Organization | Co-Chair | External | University | 2007 | |
United States – Israel Binational Science Foundation | Professional/Scientific Organization | Ad Hoc Grant Reviewer | External | International | 2007 | 2007 |
American Society for Biochemistry and Molecular Biology | Professional/Scientific Organization | Member | External | National | 2007 | |
Circulation Research | Professional/Scientific Journal | Reviewer | External | National | 2006 | |
Calhoun Cardiology Center/CVB yearly retreat | Advisory Committee | Organizer | UConn Health | University | 2006 | 2007 |
Journal of Biological Chemistry | Professional/Scientific Journal | Reviewer | National | 2005 | ||
American Heart Association | Professional/Scientific Organization | Grant Reviewer | External | National | 2005 | |
Faculty Recruitment Committee for MMSB | Advisory Committee | Member | UConn Health | University | 2005 | 2005 |
American Heart Association | Professional/Scientific Organization | Member | External | National | 2003 | |
American Heart Association | Professional/Scientific Organization | Member | External | National | 2003 | |
Journal Club for Calhoun Cardiology Center | Professional/Scientific Organization | Director | UConn Health | University | 2003 | 2010 |
Molecular Pharmacology | Professional/Scientific Journal | Reviewer | External | National | ||
Journal of Molecular Signaling | Professional/Scientific Journal | Reviewer | External | National | ||
Proceeding of the National Academy of Sciences | Professional/Scientific Journal | Reviewer | External | National | ||
British Journal of Pharmacology | Professional/Scientific Journal | Reviewer | External | National | ||
BMC Evolutionary Biology | Professional/Scientific Journal | Reviewer | External | National | ||
NIH: Molecular and Integrative Signal Transduction | Study Section | External | National |
The second messenger cAMP plays a pivotal role in the regulation of many biological processes in the heart, including calcium dynamics, contraction, and gene transcription. With an increasing number of hormones that stimulate cAMP production as well as the identification of a multitude of targets for cAMP-mediated pathways, an intriguing yet complicated question is how specificity of signaling is ensured? In other words, how does a particular hormone regulate a specific phosphorylation event when it acts via a common second messenger? The identification of scaffolding proteins that link upstream activators with their downstream targets has provided a molecular framework that allows for compartmentation of cAMP signaling pathways as well as the orchestration of spatial-temporal control over phosphorylation events.
A-Kinase Anchoring Proteins (AKAPs) are prototypical examples of scaffolding proteins that direct cAMP-responsive events while coordinating the activity of multiple signaling enzymes. AKAPs bind the regulatory subunit of the cAMP-dependent protein kinase and localize the enzyme to discrete locations within the cell. Additionally, AKAPs coordinate multiple signaling pathways through the anchoring of additional signaling enzymes such as phosphatases, phosphodiesterases, and other kinases.
My research focus is the understanding of how the specific subcellular localization of signaling enzymes regulates cardiac physiology. In particular, we have characterized a scaffolding protein termed mAKAP and demonstrated its association with several signaling enzymes including the protein phosphatase PP2A, the phosphodiesterase PDE4D3, the cAMP-dependent protein kinase PKA, the Big Map Kinase ERK5, and the transcription factor MEF2D. Furthermore, we have demonstrated how association with the complex regulates the activities of ERK5, PDE4D3 and PP2A. We are now investigating the contribution of these mAKAP-bound enzymes for the induction of cardiac hypertrophy.
Accepting Lab Rotation Students: Spring 2 Block 2025
Lab Rotation Projects
The research focus of the Dodge-Kafka laboratory is the understanding of how the specific subcellular localization of signaling enzymes regulates cardiac physiology and induction of cardiac disease. We use a variety of techniques including luciferase assays, kinase/phosphodiesterase/phosphatase assays, transfections, DNA manipulation, construction of adenoviral vectors, co-immunoprecipitations, signal cell siRNA, site-directed mutagenesis, and primary cell culture. Rotations in the lab include:
--Examining the molecular mechanisms that activate the transcription factors involved in the induction of cardiac disease
--Molecular characterization of AKAP signaling complexes
--Determining the molecular architecture of cAMP signaling domains in the heart
Other projects available and can be discussed depending on student’s interests.
Journal Articles
-
A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
Journal of molecular and cellular cardiology 2022 Aug;17226-40
-
Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy.
Gene therapy 2022 Feb;
-
Subcellular Propagation of Cardiomyocyte β-Adrenergic Activation of Calcium Uptake Involves Internal β-Receptors and AKAP7.
Function (Oxford, England) 2022 Jan;3(3):zqac020
-
Signalosome-Regulated SRF Phosphorylation Determining Myocyte Growth in Width versus Length as a Therapeutic Target for Heart Failure.
Circulation 2020 Sep;
-
mAKAPβ signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling.
Cellular signalling 2019 Jul;63109357
-
Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
The Journal of biological chemistry 2018 Dec;
-
Calcineurin/AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.
The Journal of physiology 2018 Nov;
-
Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
Journal of molecular and cellular cardiology 2018 Mar;11813-25
-
Phosphorylation state-dependent interaction between AKAP7δ/γ and phospholamban increases phospholamban phosphorylation.
Cellular signalling 2015 May;27(9):1807-15
-
RSK3: A regulator of pathological cardiac remodeling.
IUBMB life 2015 May;67(5):331-7
-
Analysis of AKAP7γ Dimerization.
Journal of signal transduction 2015 Jan;2015371626
-
P2X4 receptor-eNOS signaling pathway in cardiac myocytes as a novel protective mechanism in heart failure.
Computational and structural biotechnology journal 2015 Jan;131-7
-
mAKAP-a master scaffold for cardiac remodeling.
Journal of cardiovascular pharmacology 2014 Dec;65(3):218-25
-
The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Circulation. Heart failure 2014 Jul;7(4):663-72
-
Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure.
Circulation. Heart failure 2014 Mar;7(3):510-8
-
Scaffold state switching amplifies, accelerates, and insulates protein kinase C signaling.
The Journal of biological chemistry 2013 Dec;289(4):2353-60
-
Regulation of MEF2 transcriptional activity by calcineurin/mAKAP complexes.
Experimental cell research 2013 Feb;319(4):447-54
-
Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
Circulation research 2013 Jan;112(1):128-39
-
Spatiotemporal regulation of PKC via interactions with AKAP7 isoforms.
The Biochemical journal 2012 Sep;446(2):301-9
-
Myocyte enhancer factor 2 (MEF2) tethering to muscle selective A-kinase anchoring protein (mAKAP) is necessary for myogenic differentiation.
Cellular signalling 2012 Aug;24(8):1496-503
-
AKAPs: the architectural underpinnings of local cAMP signaling.
Journal of molecular and cellular cardiology 2012 Feb;52(2):351-8
-
LKB1 destabilizes microtubules in myoblasts and contributes to myoblast differentiation.
PloS one 2012 Jan;7(2):e31583
-
A-kinase anchoring proteins: scaffolding proteins in the heart.
American journal of physiology. Heart and circulatory physiology 2011 Nov;301(5):H1742-53
-
AKAP phosphatase complexes in the heart.
Journal of cardiovascular pharmacology 2011 Oct;58(4):354-62
-
Identification of AKAP79 as a protein phosphatase 1 catalytic binding protein.
Biochemistry 2011 Jun;50(23):5279-91
-
The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phosphatase 1 activity.
Molecular pharmacology 2011 Mar;79(3):533-40
-
Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells.
The Journal of biological chemistry 2010 Aug;285(35):26825-31
-
cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.
The Journal of biological chemistry 2010 Apr;285(15):11078-86
-
The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
Journal of molecular and cellular cardiology 2010 Feb;48(2):387-94
-
Signalosomes as therapeutic targets
Progress in Pediatric Cardiology 2008 Jan;25(1):51-56
-
Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha.
Molecular cell 2005 Dec;20(5):661-72
-
The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
Journal of cell science 2005 Dec;118(Pt 23):5637-46
-
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.
Nature 2005 Sep;437(7058):574-8
-
PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
The Biochemical journal 2004 Aug;381(Pt 3):587-92
-
Calcineurin anchoring and cell signaling.
Biochemical and biophysical research communications 2003 Nov;311(4):1111-5
-
Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360.
The Journal of biological chemistry 2002 Dec;277(50):48796-802
-
Intracellular targeting of protein kinases and phosphatases.
Diabetes 2002 Dec;51 Suppl 3(Suppl 3):S385-8
-
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.
The EMBO journal 2001 Apr;20(8):1921-30
-
AKAP79 and the evolution of the AKAP model.
FEBS letters 2000 Jun;476(1-2):58-61
-
A role for AKAP (A kinase anchoring protein) scaffolding in the loss of a cyclic adenosine 3',5'-monophosphate inhibitory response in late pregnant rat myometrium.
Molecular endocrinology (Baltimore, Md.) 1999 Dec;13(12):1977-87
-
Protein kinase A anchoring to the myometrial plasma membrane is required for cyclic adenosine 3',5'-monophosphate regulation of phosphatidylinositide turnover.
Endocrinology 1999 Nov;140(11):5165-70
-
G protein signalling pathways in myometrium: affecting the balance between contraction and relaxation.
Reviews of reproduction 1998 Sep;3(3):196-205
-
Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cbeta3 stimulation by Galphaq.
The Journal of biological chemistry 1998 Jul;273(29):18023-7
-
Evidence for inhibition by protein kinase A of receptor/G alpha(q)/phospholipase C (PLC) coupling by a mechanism not involving PLCbeta2.
Endocrinology 1998 May;139(5):2265-71
-
Molecular mechanisms regulating the effects of oxytocin on myometrial intracellular calcium
Adv Exp Med Biol 1998 Jan;449277-286
-
Oxytocin-stimulated responses in a pregnant human immortalized myometrial cell line.
Biology of reproduction 1996 Aug;55(2):427-32
-
Suppression of mouse spermatogenesis by a gonadotropin-releasing hormone antagonist and antiandrogen: failure to protect against radiation-induced gonadal damage.
Endocrinology 1996 Mar;137(3):949-55
-
cAMP at Perinuclear mAKAPα Signalosomes Is Regulated by Local Ca2+ Signaling in Primary Hippocampal Neurons.
eNeuro 8(1):
Letters
-
Cushing's syndrome mutant PKA(L)(205R) exhibits altered substrate specificity.
FEBS letters 2017 Jan;591459-467
Reviews
-
A-kinase anchoring proteins as the basis for cAMP signaling.
Handbook of experimental pharmacology 2008 Jan;(186):3-14
-
The mAKAP signalosome and cardiac myocyte hypertrophy.
IUBMB life 2007 Mar;59(3):163-9
-
The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways.
European journal of cell biology 2006 Jul;85(7):593-602
-
Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins.
Circulation research 2006 Apr;98(8):993-1001
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
mAKAP: a master regulator of cardiac hypertrophy. | Lecture | Johns Hopkins | 2019 | Baltimore, MD |
Regulation of Cardiac Hypertrophy by the A-Kinase Anchoring protein mAKAPb | Lecture | 2018 | SUNY Polytechnic Institute | |
Title: mAKAP: a master regulator of cardiac hypertrophy. | Lecture | Gordon Research Conference, Cardiac Regulatory Mechanisms | 2018 | Colby Sawyer College |
mAKAP: a master regulator of cardiac hypertrophy. | Lecture | American Heart Association, BCVS | 2018 | San Antonio, TX |
mAKAP: a master regulator of cardiac hypertrophy. | Lecture | American Heart Association, BCVS | 2018 | San Antonio, TX |
mAKAP: a master regulator of cardiac hypertrophy | Talk | University of California-Davis, Department of Pharmacology | 2017 | Davis, CA |
mAKAP: a master regulator of cardiac hypertrophy | Talk | Centre for Molecular Medicine, University of Oslo | 2017 | Oslo, Norway |
Scaffold state-switching amplifies, accelerates and insulates PKC singaling | Talk | Forth International Meeting on Anchored cAMP Signaling Pathways | 2013 | Boulder, Colorado |
AKAPs as coordinators of GPCR signaling | Talk | Endocrine Society forum on G-Protein Coupled Receptors | 2012 | Houston TX |
AKAP/phosphatase signaling complexes | Talk | Columbia University, College of Physicians and Surgeons, Department of Pharmacology | 2011 | New York City, NY |
AKAP/phosphatase signaling complexes | Talk | Third International Meeting on Anchored cAMP Signaling Pathways | 2010 | Oslo, Norway |
AKAP/Phosphatase signaling complexes | Talk | University of South Alabama, Department of Biochemistry | 2009 | Mobile, AL |
Molecular Mechanisms of cAMP Micro-Domains | Talk | International meeting on Signaling in the Cardiovascular System | 2008 | Hyannis, MA |
AKAP signaling complexes | Talk | Second International Meeting on Anchored cAMP Signaling Pathways | 2007 | Portland, OR |
Molecular Mechanisms of cAMP Micro-Domains | Talk | The Endocrine Society | 2006 | Boston, MA |
Molecular Mechanisms of cAMP Micro-Domains | Talk | Gordon Research Conference | 2006 | Biddeford, ME |
mAKAP co-ordinated signaling pathways in the heart. | Talk | University of Connecticut Health Center | 2006 | Farmington, CT |
mAKAP co-ordinated signaling pathways in the heart | Talk | University of Connecticut Dept of Physiology and Neuroscience | 2005 | Storrs, CT |
mAKAP co-ordinated signaling pathways in the heart | Talk | First International Meeting on Anchored cAMP Signaling Pathways | 2005 | Berlin, Germany |
mAKAP co-ordinated signaling pathways in the heart | Talk | Colorado State University | 2004 | Fort Collins, CO |